Literature DB >> 21193430

In mixed hematopoietic chimerism, the donor red cells win.

Matthew M Hsieh, Catherine J Wu, John F Tisdale.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21193430      PMCID： PMC3012759          DOI： 10.3324/haematol.2010.035576

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  18 in total

1.  Evidence for ineffective erythropoiesis in severe sickle cell disease.

Authors:  Catherine J Wu; Lakshamanan Krishnamurti; Jeffery L Kutok; Melinda Biernacki; Shelby Rogers; Wandi Zhang; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

2.  Altered hematopoiesis in murine sickle cell disease.

Authors:  M J Blouin; M E De Paepe; M Trudel
Journal:  Blood       Date:  1999-08-15       Impact factor: 22.113

3.  Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses.

Authors:  R Childs; E Clave; N Contentin; D Jayasekera; N Hensel; S Leitman; E J Read; C Carter; E Bahceci; N S Young; A J Barrett
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

4.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.

Authors:  Marina Cavazzana-Calvo; Emmanuel Payen; Olivier Negre; Gary Wang; Kathleen Hehir; Floriane Fusil; Julian Down; Maria Denaro; Troy Brady; Karen Westerman; Resy Cavallesco; Beatrix Gillet-Legrand; Laure Caccavelli; Riccardo Sgarra; Leila Maouche-Chrétien; Françoise Bernaudin; Robert Girot; Ronald Dorazio; Geert-Jan Mulder; Axel Polack; Arthur Bank; Jean Soulier; Jérôme Larghero; Nabil Kabbara; Bruno Dalle; Bernard Gourmel; Gérard Socie; Stany Chrétien; Nathalie Cartier; Patrick Aubourg; Alain Fischer; Kenneth Cornetta; Frédéric Galacteros; Yves Beuzard; Eliane Gluckman; Frederick Bushman; Salima Hacein-Bey-Abina; Philippe Leboulch
Journal:  Nature       Date:  2010-09-16       Impact factor: 49.962

5.  Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.

Authors:  Matthew M Hsieh; Elizabeth M Kang; Courtney D Fitzhugh; M Beth Link; Charles D Bolan; Roger Kurlander; Richard W Childs; Griffin P Rodgers; Jonathan D Powell; John F Tisdale
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

6.  Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia.

Authors:  Marco Andreani; Manuela Testi; Mariarosa Battarra; Paola Indigeno; Annalisa Guagnano; Paola Polchi; Giorgio Federici; Guido Lucarelli
Journal:  Blood Transfus       Date:  2008-07       Impact factor: 3.443

7.  Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.

Authors:  Daniela Lisini; Marco Zecca; Giovanna Giorgiani; Daniela Montagna; Rosaria Cristantielli; Massimo Labirio; Pierangela Grignani; Carlo Previderè; Alessandra Di Cesare-Merlone; Giovanni Amendola; Elena Bergami; Angela Mastronuzzi; Rita Maccario; Franco Locatelli
Journal:  Haematologica       Date:  2008-10-22       Impact factor: 9.941

8.  Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation.

Authors:  Paul M Armistead; Mehrdad Mohseni; Roslyn Gerwin; Emily C Walsh; Masoud Iravani; Bahram Chahardouli; Shahrbano Rostami; Wandi Zhang; Donna Neuberg; John Rioux; Ardeshir Ghavamzadeh; Jerome Ritz; Joseph H Antin; Catherine J Wu
Journal:  Exp Hematol       Date:  2008-06-11       Impact factor: 3.084

9.  Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia.

Authors:  Yi Kong; Suiping Zhou; Anthony J Kihm; Anne M Katein; Xiang Yu; David A Gell; Joel P Mackay; Kazuhiko Adachi; Linda Foster-Brown; Calvert S Louden; Andrew J Gow; Mitchell J Weiss
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

10.  Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.

Authors:  Marco Andreani; Manuela Testi; Javid Gaziev; Rossella Condello; Andrea Bontadini; Pier Luigi Tazzari; Francesca Ricci; Lidia De Felice; Francesca Agostini; Daniela Fraboni; Giuliana Ferrari; Mariarosa Battarra; Maria Troiano; Pietro Sodani; Guido Lucarelli
Journal:  Haematologica       Date:  2010-10-07       Impact factor: 9.941
View more
  15 in total

Review 1.  Cure for thalassemia major - from allogeneic hematopoietic stem cell transplantation to gene therapy.

Authors:  Alok Srivastava; Ramachandran V Shaji
Journal:  Haematologica       Date:  2016-12-01       Impact factor: 9.941

2.  Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease.

Authors:  Erica B Esrick; Leslie E Lehmann; Alessandra Biffi; Maureen Achebe; Christian Brendel; Marioara F Ciuculescu; Heather Daley; Brenda MacKinnon; Emily Morris; Amy Federico; Daniela Abriss; Kari Boardman; Radia Khelladi; Kit Shaw; Helene Negre; Olivier Negre; Sarah Nikiforow; Jerome Ritz; Sung-Yun Pai; Wendy B London; Colleen Dansereau; Matthew M Heeney; Myriam Armant; John P Manis; David A Williams
Journal:  N Engl J Med       Date:  2020-12-05       Impact factor: 91.245

Review 3.  Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned.

Authors:  Richard A Morgan; David Gray; Anastasia Lomova; Donald B Kohn
Journal:  Cell Stem Cell       Date:  2017-11-02       Impact factor: 24.633

4.  Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide.

Authors:  N A Fouzia; E S Edison; K M Lakshmi; A Korula; S R Velayudhan; P Balasubramanian; A Abraham; A Viswabandya; B George; V Mathews; A Srivastava
Journal:  Bone Marrow Transplant       Date:  2017-10-16       Impact factor: 5.483

5.  Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.

Authors:  Megan D Hoban; Gregory J Cost; Matthew C Mendel; Zulema Romero; Michael L Kaufman; Alok V Joglekar; Michelle Ho; Dianne Lumaquin; David Gray; Georgia R Lill; Aaron R Cooper; Fabrizia Urbinati; Shantha Senadheera; Allen Zhu; Pei-Qi Liu; David E Paschon; Lei Zhang; Edward J Rebar; Andrew Wilber; Xiaoyan Wang; Philip D Gregory; Michael C Holmes; Andreas Reik; Roger P Hollis; Donald B Kohn
Journal:  Blood       Date:  2015-03-02       Impact factor: 22.113

6.  Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies.

Authors:  Marco Andreani; Manuela Testi; Mariarosa Battarra; Guido Lucarelli
Journal:  Chimerism       Date:  2011-01

Review 7.  Umbilical cord blood: an evolving stem cell source for sickle cell disease transplants.

Authors:  Shalini Shenoy
Journal:  Stem Cells Transl Med       Date:  2013-04-11       Impact factor: 6.940

8.  At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT.

Authors:  Courtney D Fitzhugh; Stefan Cordes; Tiffani Taylor; Wynona Coles; Katherine Roskom; Mary Link; Matthew M Hsieh; John F Tisdale
Journal:  Blood       Date:  2017-09-08       Impact factor: 22.113

9.  Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions.

Authors:  Shalini Shenoy
Journal:  Ther Adv Hematol       Date:  2013-10

10.  Genome editing of HBG1 and HBG2 to induce fetal hemoglobin.

Authors:  Jean-Yves Métais; Phillip A Doerfler; Thiyagaraj Mayuranathan; Daniel E Bauer; Stephanie C Fowler; Matthew M Hsieh; Varun Katta; Sagar Keriwala; Cicera R Lazzarotto; Kevin Luk; Michael D Neel; S Scott Perry; Samuel T Peters; Shaina N Porter; Byoung Y Ryu; Akshay Sharma; Devlin Shea; John F Tisdale; Naoya Uchida; Scot A Wolfe; Kaitly J Woodard; Yuxuan Wu; Yu Yao; Jing Zeng; Shondra Pruett-Miller; Shengdar Q Tsai; Mitchell J Weiss
Journal:  Blood Adv       Date:  2019-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.